$ALGN

Align Technology (ALGN) Gund-related holders report 5.4% beneficial stake

Align Technology, Inc. (ALGN) disclosed an Amendment No. 1 to a Schedule 13G filed by Gund-related holders. The reporting persons, including G. Zachary Gund and Grant Gund, beneficially own 3,812,981 shares, or 5.4% of ALGN common stock, based on 71,039,852 shares outstanding as of July 31, 2026.

Original reporting
Published Aug 12, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 9:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ALGN
Neutral
medium confidence
Mentioned
$ALGN
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ALGNNeutralLow
01

Why it matters

The disclosure updates beneficial ownership totals and percentages, which can matter for monitoring large holders and potential future activism, but it does not include any new corporate action or company-specific catalyst.

02

Market read

Primarily a large-holder tracking update with limited immediate fundamental implications.

03

What to watch

Traders may overinterpret passive beneficial ownership as activism; the filing text does not indicate intent to change strategy, governance, or pursue a deal.

Relevance 4/10Novelty 4/10Timing: filing dated for an amendment reported on 2026-08-12

Background

The article is an SEC Schedule 13G amendment (beneficial ownership) for Align Technology, listing multiple Gund-related trusts and foundations as reporting persons.

Company-level read

Ticker impact

$ALGNNeutralMedium confidence
Context

Align Technology is the issuer of a Schedule 13G amendment showing Gund-related holders beneficially own 3,812,981 shares, 5.4% of outstanding.

Expected impact

Low near-term impact; any move is likely limited to positioning/flow effects rather than fundamentals.

Evidence & confidence

The filing updates ownership percentages and share counts as of July 31, 2026, but provides no new business, guidance, or transaction terms that would directly reprice the company.

Market effects

Minimal. Ownership disclosure does not change sector fundamentals for dental/orthodontic tech.

None indicated.

None indicated.

Counterpoint

The 5.4% figure could reflect aggregation across trusts and managers rather than a fresh accumulation signal, limiting any trading edge.

Key entities

  • Align Technology, Inc.

    Subject of the Schedule 13G amendment; beneficial ownership reported at 5.4% in aggregate by Gund-related reporting persons.

  • G. Zachary Gund and related trusts/foundations

    Reporting persons whose aggregated beneficial ownership is disclosed as 3,812,981 shares (5.4%).

Related articles

$ALGNMed

Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology said a Jinan Intermediate People’s Court issued a first-instance ruling on Aug. 10, 2026 in a China patent case against Angel. The court found Angel’s MasterForce and ATreat systems infringe Align’s CN113693748B patent and ordered Angel to stop use, manufacturing, and sales, awarding RMB 10 million in damages. Angel can appeal to China’s Supreme People’s Court.

$ALGNMed

Align Technology, Inc.: Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology (Nasdaq: ALGN) said China’s Jinan Intermediate People’s Court ruled in its favor in a patent infringement case against Angelalign’s China subsidiaries. The court found Angel infringed Align’s CN113693748B patent tied to extraction-gap-closure technology, ordering a stop to use and sales in China and awarding RMB 10 million in damages. Angel can appeal.

$DDDMed

3D Printing Financials: 3D Systems, Prodways, and Align Build on Positive Momentum - 3DPrint.com

3D Systems reported Q2 revenue of $94.6M, flat YoY, with healthcare up 6.8% and aerospace/defense and data center infrastructure each growing over 20%. Adjusted EBITDA loss narrowed to $0.8M. It expects Q3 revenue of $96M to $99M. Prodways posted Q2 revenue of €10.5M (+5% YoY) and plans a €20M buyback. Align Technology reported record Q2 revenue of just over $1.05B (+4.3%), with clear aligner revenue up 8.2% and 2026 revenue growth guidance of 3% to 4%.

$ALGNMedAI 9/10

Align Technology (ALGN) Q2 2026 Earnings Call Transcript

Align Technology (ALGN) reported Q2 2026 revenue of $1,056.2 million, up 4.3% y/y, driven by record Clear Aligner volumes and higher ASPs. Clear Aligner revenue rose 8.2% to $870.9 million on 691,785 cases. Systems and Services revenue fell 10.8% to $185.3 million. Q3 revenue guidance is $1.00 to $1.02 billion; full-year growth 3% to 4%.

$ALGNMed

Align Technology To Add Three Directors And Raise 2026 Share Repurchases To Up To $500 Million

Align Technology said it will add three independent directors and increase its 2026 share repurchase authorization to $400 million to $500 million, following discussions with Elliott Investment Management. Align also launched a strategy and operating model review with an unnamed consulting firm, targeting improved execution and scalability. Align develops Invisalign and related digital dentistry tools.